Dupilumab provides sustained effectiveness in patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis up to 5-year results from the daily practice BioDay Registry

Activity: Talk and presentation › Academic presentation › Academic

Period13-Oct-2023
Event titleEuropean Academy Dermatology and Venereology congress 2023
Event typeConference
LocationBerlin, GermanyShow on map
Degree of RecognitionInternational